HOWL Werewolf Therapeutics, Inc. Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
16:51
Jan 27
Jan 27
HOWL to double on clinical results
The author argues HOWL.US could gain 100% within the first half of the year, driven by upcoming test/clinical results, and recommends buying while it is cheap. A technical setup suggests a possible 30% single-day breakout. The author acknowledges binary, results-driven risk, financial losses, and potential shareholder dilution from funding needs.
MED
About HOWL Investor Commentary
Across the available history and selected sources, Buzzberg tracks HOWL (Werewolf Therapeutics, Inc.) across 1 sources: 1 bullish vs 0 bearish calls from 1 authors. Historical directional balance: 100% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 1 total trade idea tracked. Latest voices: u/BeautifulPiccolo6242.